Frequency and Significance of Abnormal Pancreatic Imaging in Patients with BRCA1 and BRCA2 Genetic Mutations
Objective. Pancreatic adenocarcinoma is typically diagnosed in advanced stages resulting in a significant reduction in the number of patients who are candidates for surgical resection. Although the majority of cases are believed to occur sporadically, about 10% show familial clustering and studies h...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Scientifica |
| Online Access: | http://dx.doi.org/10.1155/2016/5619358 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832558995223609344 |
|---|---|
| author | Elie Chahla Antonio Cheesman Suzanne M. Mahon Robert W. Garrett Ben P. Bradenham Theresa L. Schwartz Louay Omran Jason R. Taylor Samer Alkaade |
| author_facet | Elie Chahla Antonio Cheesman Suzanne M. Mahon Robert W. Garrett Ben P. Bradenham Theresa L. Schwartz Louay Omran Jason R. Taylor Samer Alkaade |
| author_sort | Elie Chahla |
| collection | DOAJ |
| description | Objective. Pancreatic adenocarcinoma is typically diagnosed in advanced stages resulting in a significant reduction in the number of patients who are candidates for surgical resection. Although the majority of cases are believed to occur sporadically, about 10% show familial clustering and studies have identified an increased frequency of BRCA germline mutations. The role of screening for pancreatic adenocarcinoma in these populations is unclear. Our study aims to identify the abnormal pancreatic imaging findings in BRCA1 and BRCA2 mutation carriers. Methods. A retrospective review of patient medical records with known BRCA1 and BRCA2 mutations was conducted. Data was collected and all available abdominal imaging studies were reviewed. Results. A total of 66 patients were identified, 36 with BRCA1 and 30 with BRCA2 mutations. Only 20/66 (30%) had abdominal imaging (14 BRCA1 and 6 BRCA2 patients). Of those patients with abdominal imaging, abnormal pancreatic imaging findings were detected in 7/20 (35%) cases. Conclusion. Our study shows a high incidence of abnormal pancreatic imaging findings in patients with BRCA genetic mutations (35%). Larger studies are needed to further define the role of pancreatic cancer screening and the significance of abnormal imaging findings in BRCA1 and BRCA2 mutation carriers. |
| format | Article |
| id | doaj-art-517c7394e8bb453cb38b912cbbe483a3 |
| institution | Kabale University |
| issn | 2090-908X |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Scientifica |
| spelling | doaj-art-517c7394e8bb453cb38b912cbbe483a32025-02-03T01:31:09ZengWileyScientifica2090-908X2016-01-01201610.1155/2016/56193585619358Frequency and Significance of Abnormal Pancreatic Imaging in Patients with BRCA1 and BRCA2 Genetic MutationsElie Chahla0Antonio Cheesman1Suzanne M. Mahon2Robert W. Garrett3Ben P. Bradenham4Theresa L. Schwartz5Louay Omran6Jason R. Taylor7Samer Alkaade8Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, MO 63110, USADepartment of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO 63110, USADivision of Hematology and Oncology, Saint Louis University School of Medicine, St. Louis, MO 63110, USADepartment of Radiology, Saint Louis University School of Medicine, St. Louis, MO 63110, USADivision of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, MO 63110, USADepartment of General Surgery, Saint Louis University School of Medicine, St. Louis, MO 63110, USADivision of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, MO 63110, USADivision of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, MO 63110, USADivision of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, MO 63110, USAObjective. Pancreatic adenocarcinoma is typically diagnosed in advanced stages resulting in a significant reduction in the number of patients who are candidates for surgical resection. Although the majority of cases are believed to occur sporadically, about 10% show familial clustering and studies have identified an increased frequency of BRCA germline mutations. The role of screening for pancreatic adenocarcinoma in these populations is unclear. Our study aims to identify the abnormal pancreatic imaging findings in BRCA1 and BRCA2 mutation carriers. Methods. A retrospective review of patient medical records with known BRCA1 and BRCA2 mutations was conducted. Data was collected and all available abdominal imaging studies were reviewed. Results. A total of 66 patients were identified, 36 with BRCA1 and 30 with BRCA2 mutations. Only 20/66 (30%) had abdominal imaging (14 BRCA1 and 6 BRCA2 patients). Of those patients with abdominal imaging, abnormal pancreatic imaging findings were detected in 7/20 (35%) cases. Conclusion. Our study shows a high incidence of abnormal pancreatic imaging findings in patients with BRCA genetic mutations (35%). Larger studies are needed to further define the role of pancreatic cancer screening and the significance of abnormal imaging findings in BRCA1 and BRCA2 mutation carriers.http://dx.doi.org/10.1155/2016/5619358 |
| spellingShingle | Elie Chahla Antonio Cheesman Suzanne M. Mahon Robert W. Garrett Ben P. Bradenham Theresa L. Schwartz Louay Omran Jason R. Taylor Samer Alkaade Frequency and Significance of Abnormal Pancreatic Imaging in Patients with BRCA1 and BRCA2 Genetic Mutations Scientifica |
| title | Frequency and Significance of Abnormal Pancreatic Imaging in Patients with BRCA1 and BRCA2 Genetic Mutations |
| title_full | Frequency and Significance of Abnormal Pancreatic Imaging in Patients with BRCA1 and BRCA2 Genetic Mutations |
| title_fullStr | Frequency and Significance of Abnormal Pancreatic Imaging in Patients with BRCA1 and BRCA2 Genetic Mutations |
| title_full_unstemmed | Frequency and Significance of Abnormal Pancreatic Imaging in Patients with BRCA1 and BRCA2 Genetic Mutations |
| title_short | Frequency and Significance of Abnormal Pancreatic Imaging in Patients with BRCA1 and BRCA2 Genetic Mutations |
| title_sort | frequency and significance of abnormal pancreatic imaging in patients with brca1 and brca2 genetic mutations |
| url | http://dx.doi.org/10.1155/2016/5619358 |
| work_keys_str_mv | AT eliechahla frequencyandsignificanceofabnormalpancreaticimaginginpatientswithbrca1andbrca2geneticmutations AT antoniocheesman frequencyandsignificanceofabnormalpancreaticimaginginpatientswithbrca1andbrca2geneticmutations AT suzannemmahon frequencyandsignificanceofabnormalpancreaticimaginginpatientswithbrca1andbrca2geneticmutations AT robertwgarrett frequencyandsignificanceofabnormalpancreaticimaginginpatientswithbrca1andbrca2geneticmutations AT benpbradenham frequencyandsignificanceofabnormalpancreaticimaginginpatientswithbrca1andbrca2geneticmutations AT theresalschwartz frequencyandsignificanceofabnormalpancreaticimaginginpatientswithbrca1andbrca2geneticmutations AT louayomran frequencyandsignificanceofabnormalpancreaticimaginginpatientswithbrca1andbrca2geneticmutations AT jasonrtaylor frequencyandsignificanceofabnormalpancreaticimaginginpatientswithbrca1andbrca2geneticmutations AT sameralkaade frequencyandsignificanceofabnormalpancreaticimaginginpatientswithbrca1andbrca2geneticmutations |